Advertisement
Singapore markets close in 1 hour 53 minutes
  • Straits Times Index

    3,324.92
    +10.78 (+0.33%)
     
  • Nikkei

    39,173.15
    +368.50 (+0.95%)
     
  • Hang Seng

    17,997.42
    -30.29 (-0.17%)
     
  • FTSE 100

    8,281.55
    0.00 (0.00%)
     
  • Bitcoin USD

    61,113.10
    -1,229.58 (-1.97%)
     
  • CMC Crypto 200

    1,268.38
    +19.26 (+1.54%)
     
  • S&P 500

    5,447.87
    -16.75 (-0.31%)
     
  • Dow

    39,411.21
    +260.88 (+0.67%)
     
  • Nasdaq

    17,496.82
    -192.54 (-1.09%)
     
  • Gold

    2,339.20
    -5.20 (-0.22%)
     
  • Crude Oil

    81.60
    -0.03 (-0.04%)
     
  • 10-Yr Bond

    4.2480
    -0.0090 (-0.21%)
     
  • FTSE Bursa Malaysia

    1,587.50
    -2.16 (-0.14%)
     
  • Jakarta Composite Index

    6,864.38
    -24.78 (-0.36%)
     
  • PSE Index

    6,299.05
    +26.59 (+0.42%)
     

Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference

Organogenesis Holdings Inc.
Organogenesis Holdings Inc.

CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the Truist Securities MedTech Conference, which is being held at the InterContinental Boston in Boston, MA on Tuesday, June 18th. Management will participate in 1x1 meetings. There will be no formal presentation.

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com.

CONTACT: Investor Inquiries: ICR Westwicke Mike Piccinino, CFA OrganoIR@westwicke.com Press and Media Inquiries: Organogenesis communications@organo.com